Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNextEnergy Solar Regulatory News (NESF)

Share Price Information for NextEnergy Solar (NESF)

Share Price is delayed by 15 minutes
Get Live Data
46.20    -0.80 (-1.70%)
Bid:
46.15
Ask:
46.70
Spread: 0.55 (1.192%)
Market Cap: £265.74m
NESF Live PriceLast checked at - London Stock Exchange

Intraday NextEnergy Solar Share Chart

QuotedData's Weekly News & Interview

2 Feb 2024 16:00

RNS Number : 9167B
NextEnergy Solar Fund Limited
02 February 2024
 

 

QuotedData's Weekly News Show - Andrew McHattie from The Investment Trust Newsletter & ?Ross Grier from NextEnergy Capital

On 2nd February, James Carthew and Andrew McHattie talked through the Weekly News and interviewed this week's special guest: Ross Grier - Watch here.

About our Weekly Show:

The best way to enjoy the show is to join our weekly webinar live, at 11 am every Friday, where we discuss the key stories and events in the investment companies' sector over the last week. We also invite a guest every week and give you the opportunity to get answers to your questions.

Click here to view our previous recordings: https://quoteddata.com/events/?past=true

Click here to view our upcoming events: https://quoteddata.com/events/

This information is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

This website is for information purposes only and is not intended to encourage the reader to deal in any mentioned securities. QuotedData is a trading name of Marten & Co Limited, which is authorised and regulated by the Financial Conduct Authority. Some of the content in this website is sponsored and, although it abides by Content Principles and Objectives, (/about-quoteddata/research-principles-objectives/) it is considered non-independent. Investments may involve a significant degree of risk, including loss of capital. The value of an investment and the income from it could go down as well as up. The return of your investment is not guaranteed, and you may get back less than you originally invested. Past performance is not an indicator of future performance. It is important that you read the Terms and Conditions (/about-quoteddata/terms-and-conditions/) before considering any investment.

QUOTEDDATA50 Gresham Street | London | EC2V 7AY | UKTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABUGDDCDGDGSD
Date   Source Headline
3rd Jun 20267:00 amRNSQuarterly NAV & Operational Update
18th May 202610:06 amRNSDirector Declaration
7th May 20267:00 amRNSDividend Declaration
17th Apr 20263:42 pmRNSCarbon Price Support Removal
11th Mar 20267:00 amRNSStrategic Review, Reset & Roadmap
18th Feb 20267:00 amRNSQuarterly NAV & Operating Update
16th Feb 20261:03 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSThird Interim Dividend Declaration
28th Jan 20269:31 amRNSGovernment Response to RoC and FiT Consultation
3rd Dec 20257:01 amRNSDirector Roles and Responsibilities
3rd Dec 20257:00 amRNSInterim Results & Interim Report
26th Nov 20257:00 amRNSAppointment of Chair
11th Nov 20257:00 amRNSPotential Impact of ROC and FiT Consultation
6th Nov 20257:01 amRNSNotice of Interim Results
6th Nov 20257:00 amRNSInterim Dividend Declaration
19th Sep 202510:28 amRNSDirector Declaration
21st Aug 20257:00 amRNSNet Asset Value & Operating Update
20th Aug 20253:13 pmRNSResult of AGM
7th Aug 20257:00 amRNSInterim Dividend Declaration
17th Jul 20257:00 amRNSNotice of AGM
19th Jun 20257:00 amRNSReduced Investment Management Fee
16th Jun 20257:01 amRNSPublication of Sustainability & ESG Report
16th Jun 20257:00 amRNSFull Year Results & Annual Report
22nd May 20259:01 amRNSNotice of Full Year Results
22nd May 20259:00 amRNSDirectors’ Roles, Functions and Responsibilities
15th May 20251:36 pmRNSDirectorate Change & Chair Succession
15th May 20257:02 amRNSTwelfth Dividend Target
15th May 20257:01 amRNSNet Asset Value & Operating Update
15th May 20257:00 amRNSInterim Dividend Declaration
1st May 20257:01 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 202511:16 amRNS-RQuotedData's In The HotSeat
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.